- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus, Non-Insulin-Dependent in India
Total 476 results
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, United States, India, Israel, Italy, Russian Federation, Japan, Finland, Serbia, Turkey, Bulgaria, Estonia, Czechia, Lithuania, Ukraine, Poland, Latvia, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Poland, Germany, Bulgaria, Peru, Russian Federation, Mexico, Hungary, South Africa, Latvia, New Zealand, Costa Rica, India, Czechia, Romania, Lithuania, Puerto Rico, Chile
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Colombia, Mexico, Portugal, Bulgaria, India, Malaysia, Turkey, Ukraine, Greece, Sweden, Singapore, Czech Republic, Argentina, Puerto Rico, Russian Federation, Thailand, Slovakia, Latvia, Estonia, Peru
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Germany, Puerto Rico, United Kingdom, Spain, Canada, Brazil, Korea, Republic of, India, Israel, Russian Federation, South Africa
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Spain, India, Belgium, Argentina, Austria, France, Mexico
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyFrance, Poland, United States, Belgium, Germany, Spain, India, Romania, South Africa, Canada, Australia, Korea, Republic of, New Zealand, Russian Federation, Brazil, Malaysia, Latvia, Mexico
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Puerto Rico, Mexico, Philippines, India, Peru
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, United Kingdom, Korea, Republic of, Peru, South Africa, India
-
NovartisCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencySpain, Canada, France, Germany, Australia, Costa Rica, Finland, Russian Federation, Argentina, India, Norway, Sweden
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Canada, France, Poland, Germany, Israel, India, Ukraine, Korea, Republic of, Malaysia, Netherlands, New Zealand, Singapore, Brazil, Austria, Denmark, Belgium
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Germany, Israel, Bulgaria, Costa Rica, India, Romania, Ukraine, Finland, Korea, Republic of, Canada, Philippines, Russian Federation, Argentina, Norway, Denmark, Slovakia, Mexico, Puerto Rico
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, France, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Spain, United Kingdom, Vietnam, Germany, Philippines, Malaysia, Sweden, Estonia, Latvia, Lithuania, Finland, Norway and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Germany, Estonia, Russian Federation, South Africa, India, Ukraine, Mexico, Greece, New Zealand, Poland, Czechia, Lithuania, Romania, Puerto Rico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, India, Italy, Argentina, France, Germany, Mexico, Puerto Rico
-
Novartis PharmaceuticalsTerminatedCardiovascular Disease | Type 2 Diabetes MellitusSpain, China, United States, Belgium, Colombia, South Africa, Italy, United Kingdom, Germany, Hungary, Japan, Taiwan, Turkey, Netherlands, Greece, Switzerland, Austria, France, Thailand, Argentina, Canada, Singapore, Lithuania, Sweden, ... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Peru, Israel, Australia, United Kingdom, Korea, Republic of, Spain, Philippines
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Taiwan, South Africa, Korea, Republic of, Spain, Brazil, India, Peru, Philippines, United Kingdom, Hong Kong, France, Mexico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Greece, Argentina, Korea, Republic of, Brazil, Czechia, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
GlaxoSmithKlinePopulation Health Research InstituteTerminatedDiabetes Mellitus, Type 2United States, Germany, Russian Federation, Netherlands, South Africa, Sweden, Canada, Norway, United Kingdom, Latvia, Thailand, Colombia, India, Peru, Romania, Pakistan, Slovakia, Finland, Chile, Denmark, Argentina, Mexico, Czech Republic and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Mexico, Peru, Russian Federation, United Kingdom, Philippines, South Africa, Spain, Hong Kong, Albania
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Brazil, Canada, China, Germany, India, Israel, Italy, Japan, Korea, Republic of, Mexico, Puerto Rico, Russian Federation, Saudi Arabia, Spain, Turkey, United Arab Emirates, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Australia, United States, Italy, Argentina, Canada, Mexico, India, Peru, Spain, Denmark, France, Singapore, Puerto Rico
-
AstraZenecaCompletedDiabetesTaiwan, United States, Russian Federation, India
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Peripheral Arterial DiseaseSpain, Taiwan, China, India, United States, Canada, Thailand, Austria, Malaysia, Germany, Poland, Japan, Czechia, Greece, Belgium, Denmark, Hungary, Latvia, Norway, Sweden
-
Torrent Pharmaceuticals LimitedIqvia Pty LtdUnknownHypertension | Diabetes | DyslipidemiasPhilippines, Brazil, India
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, Canada, Croatia, Hungary, India
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, Argentina
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Chronic Kidney Diseases | Type 2 Diabetes MellitusEstonia, Belgium, Sweden, Italy, China, United States, Canada, Bulgaria, Chile, Denmark, Hungary, Latvia, Mexico, Russian Federation, Serbia, Spain, Portugal, Romania, Turkey, Poland, Lithuania, Argentina, Australia, Brazil, Czechia, France, Georg... and more
-
The George InstituteServierCompletedDiabetes Mellitus, Type 2Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyUnited States, Canada, France, Hong Kong, India, Malaysia, Netherlands, Philippines, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, France, Spain, Sweden, China, Korea, Republic of, United States, Canada, Germany, Ireland, Mexico, Poland, India, Denmark, Hungary, United Kingdom, New Zealand, Malaysia, Netherlands, Russian Federation, Thailand, Romania, Ita... and more
-
AstraZenecaCompletedDiabetesUnited States, Mexico, Argentina, Brazil, Puerto Rico, Russian Federation, Germany, Italy, Ukraine, India, Hungary, Poland, Philippines